Immune Regulation News 10.34 September 7, 2018 | |
| |
TOP STORYNotch-deficient alloantigen-specific T cells showed no early defects in proliferation or helper polarization in vivo, but subsequently exhibited markedly decreased cytokine secretion and enhanced accumulation of FoxP3+ regulatory T cells. [Blood] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)SMAD4 Promotes TGF-β-Independent NK Cell Homeostasis and Maturation and Antitumor Immunity Researchers demonstrated that selective deletion of Smad4 in natural killer (NK) cells led to dramatically reduced tumor cell rejection and augmented tumor cell metastases, reduced murine cytomegalovirus clearance, as well as impeded NK cell homeostasis and maturation. [J Clin Invest] Abstract | Full Article | Graphical Abstract Investigators showed gut microbiota-derived short-chain fatty acids (SCFAs) promoted microbiota antigen-specific Th1 cell IL-10 production, mediated by G-protein coupled receptor 43. SCFAs activated Th1 cell STAT3 and mTOR, and consequently upregulated transcription factor B lymphocyte-induced maturation protein 1, which mediates SCFA-induction of IL-10. [Nat Commun] Full Article The authors showed that two stage-specific Cd4 cis-elements, the previously characterized enhancer E4p and a novel enhancer E4m, coordinately promoted Cd4 transcription in mature thymic MHC-II-specific T cells, in part through the canonical Wnt pathway. [Nat Commun] Full Article Rapid CLIP Dissociation from MHC II Promotes an Unusual Antigen Presentation Pathway in Autoimmunity Researchers generated knock-in non-obese diabetic mice with a single amino acid change in the chain–derived class II–associated invariant chain peptide (CLIP) segment of the invariant chain in order to moderately slow CLIP dissociation from I-Ag7. [J Exp Med] Abstract The Human Lymph Node Microenvironment Unilaterally Regulates T-Cell Activation and Differentiation Human tonsil and lymph node-derived fibroblastic reticular cells (FRCs) constrained the proliferation of both naïve and pre-activated T cells, skewing their differentiation away from a central memory T-cell phenotype. FRCs acted unilaterally without requiring T-cell feedback, imposing suppression via indoleamine-2,3-dioxygenase, adenosine 2A Receptor, prostaglandin E2, and transforming growth factor beta receptor. [PLoS Biol] Full Article | Press Release In the thymus, kindlin-3 promoted intrathymic T cell proliferation by facilitating the integrin-dependent crosstalk with thymic antigen presenting cells, while intrathymic T cell migration, maturation into single positive CD4 and CD8 T cells and release into the circulation proceeded without kindlin-3. [Elife] Full Article Scientists found that the formation of nodular inflammatory foci (NIFs) was essential to reduce the number of infected cells in lung tissue, showing that NIFs were sites of infection as well as sites of immune response. T cells had to be present in NIFs in high numbers, and CD4 as well as CD8 T cells supported each other to efficiently control virus spread. [PLoS Pathog] Full Article Researchers demonstrated that nuclear translocation of NF-kB was significantly inhibited in siRNA-mediated knock-down of protein phosphatase-1α (PP1α) or dominant-negative PP1α cells. Sub-population analysis revealed that defective nuclear translocation of NF-kB was most prominent in CD4+CD45RA–CXCR3– T-cells that included IL-10-producing TH2 cells. [Mol Cell Biol] Abstract Subscribe to our sister publications: Human Immunology News & Immunology of Infectious Disease News. | |
| |
REVIEWSForkhead Box Transcription Factors as Context-Dependent Regulators of Lymphocyte Homeostasis Focusing on the various mechanisms by which their functional activity is modulated, as well as on their mechanisms of action, the authors discuss how specific forkhead box transcription factors control lymphocyte function, allowing for the establishment and maintenance of immune homeostasis. [Nat Rev Immunol] Abstract Nutritional Modulation of Innate Immunity: The Fat–Bile–Gut Connection Investigators summarize how nutrition modulates innate immunity. They discuss how the integration of postprandial signals by the gut microbiota, along with the absorption routes of metabolites, differentially affects immune niches to orchestrate immune responses. Finally, they discuss the potential consequences of these signals in the light of trained immunity. [Trends Endocrinol Metab] Abstract Visit our reviews page to see a complete list of reviews in the immune regulation research field. | |
| |
INDUSTRY NEWSCheckmate Pharmaceuticals announced that it has entered into a clinical trial collaboration and supply agreement with the alliance between Merck KGaA, Darmstadt, Germany, and Pfizer to evaluate CMP-001, a TLR9 agonist, in combination with avelumab, a human anti-PD-L1 antibody. [Checkmate Pharmaceuticals] Press Release Turnstone Biologics and the La Jolla Institute for Allergy and Immunology announced that they have entered into a collaboration and licensing agreement whereby Turnstone will utilize La Jolla Institute’s proprietary neoantigen identification methodology to select personalized neoantigens to target with its proprietary viral technologies for the development of new cancer immunotherapies. [Turnstone Biologics (Business Wire, Inc.)] Press Release Tezepelumab Granted Breakthrough Therapy Designation by US FDA AstraZeneca and its partner Amgen Inc. announced that the US FDA has granted breakthrough therapy designation for tezepelumab in patients with severe asthma, without an eosinophilic phenotype, who are receiving inhaled corticosteroids/long-acting beta2-agonists with or without oral corticosteroids and additional asthma controllers. [AstraZeneca] Press Release Update on TULIP 1 Phase III Trial for Anifrolumab in Systemic Lupus Erythematosus AstraZeneca and MedImmune announced top-line results from the TULIP 1 Phase III trial for anifrolumab in adult patients with moderate-to-severe systemic lupus erythematosus (SLE). The trial did not meet the primary endpoint of a statistically-significant reduction in disease activity in patients with SLE as measured by the SLE Responder Index 4 at 12 months. [AstraZeneca] Press Release Immusoft Receives $3.5 Million Grant to Expand upon Its Cell Therapy Platform Immusoft Corporation announced that it has received a Phase II small business innovation research grant from the National Institute of General Medical Sciences, part of the National Institutes of Health. The grant, in the amount of just over $3.5 million, will enable Immusoft to further advance its modified B cell approach to treating disease. [Immusoft Corporation (Business Wire, Inc.)] Press Release | |
| |
POLICY NEWSPeer Reviewers Unmasked: Largest Global Survey Reveals Trends Scientists in developed countries provide nearly three times as many peer reviews per paper submitted as researchers in emerging nations, according to the largest ever survey of the practice. [Nature News] Editorial The Trump administration’s restrictions on hiring foreign scientists are making it more difficult for the agency to attract top scientific talent, a top FDA official said. “[The policy] definitely has created an additional challenge, I think, for us,” said Melanie Keller, the FDA’s acting associate commissioner for scientific and clinical recruitment. [STAT News] Editorial Russian Scientists Gain Access to Springer Nature Content through National License Agreement Springer Nature and the Russian Foundation for Basic Research (RFBR) have signed a major agreement that will benefit researchers, post docs and students based at Russian research institutions. Oleg Belyavsky, Director of the Russian Foundation for Basic Research, said: “The launch of this national subscription is a highly important step for RFBR and the Russian research and academic community.” [Springer Nature Switzerland AG] Editorial
| |
EVENTSNEW Keystone Symposia: Uncovering Mechanisms of Immune-Based Therapy in Cancer and Autoimmunity NEW Keystone Symposia: Cancer Immunotherapy – Mechanistic Insights to Improve Clinical Benefit NEW Keystone Symposia: Cancer Metastasis – The Role of Metabolism, Immunity and the Microenvironment Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Faculty Position – Immunology (Vanderbilt University Medical Center) Research Technologist – Cell Separation (STEMCELL Technologies Inc.) Postdoctoral Fellowship – Immunology (University of Nantes) Postdoctoral Position – B-Cell Memory (Institut Necker-Enfants Malades) Postdoctoral Fellow/Research Scientist – Cancer Research (Icahn School of Medicine at Mount Sinai) Department Chair – Inflammation & Immunity (Cleveland Clinic – Lerner Research Institute) Research Associate – Innate Immune Response to Bacterial Infection (Imperial College London) Faculty Position – Aging and the Immune System (Mayo Clinic) Postdoctoral Fellow – Immunotherapy (California Institute for Biomedical Research) PhD Student – Cellular Immunotherapy (Glycostem Therapeutics) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immune Regulation News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|